Cormorant Asset Management, LP Biomea Fusion, Inc. Transaction History
Cormorant Asset Management, LP
- $1.74 Billion
- Q1 2024
A detailed history of Cormorant Asset Management, LP transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Cormorant Asset Management, LP holds 3,570,872 shares of BMEA stock, worth $16.1 Million. This represents 3.07% of its overall portfolio holdings.
Number of Shares
3,570,872
Previous 3,570,872
-0.0%
Holding current value
$16.1 Million
Previous $51.8 Million
2.96%
% of portfolio
3.07%
Previous 3.12%
Shares
2 transactions
Others Institutions Holding BMEA
# of Institutions
121Shares Held
25.7MCall Options Held
2.56MPut Options Held
879K-
State Street Corp Boston, MA4.49MShares$20.2 Million0.0% of portfolio
-
Laurion Capital Management LP New York, NY2.72MShares$12.2 Million0.36% of portfolio
-
Baker Bros. Advisors LP New York, NY2.11MShares$9.49 Million0.4% of portfolio
-
Black Rock Inc. New York, NY1.97MShares$8.88 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.37MShares$6.15 Million0.0% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $132M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...